Cafer Zorkun
Cafer Zorkun
Other namesC Zorkun, Cafer Sadık Zorkun
Verified email at
Cited by
Cited by
Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ...
New England Journal of Medicine 373 (23), 2247-2257, 2015
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …
AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ...
European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022
Early versus delayed, provisional eptifibatide in acute coronary syndromes
RP Giugliano, JA White, C Bode, PW Armstrong, G Montalescot, BS Lewis, ...
New England Journal of Medicine 360 (21), 2176-2190, 2009
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
R Bentley-Lewis, D Aguilar, MC Riddle, B Claggett, R Diaz, K Dickstein, ...
American heart journal 169 (5), 631-638. e7, 2015
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON–TIMI 38 (trial to assess …
YB Pride, P Tung, S Mohanavelu, C Zorkun, SD Wiviott, EM Antman, ...
JACC: Cardiovascular Interventions 3 (8), 806-811, 2010
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years
V Kunadian, C Harrigan, C Zorkun, AM Palmer, KJ Ogando, LH Biller, ...
Journal of thrombosis and thrombolysis 27, 316-328, 2009
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial …
YB Pride, SD Wiviott, JL Buros, C Zorkun, MU Tariq, EM Antman, ...
American heart journal 158 (3), e21-e26, 2009
Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes)
V Kunadian, SK James, DM Wojdyla, C Zorkun, J Wu, RF Storey, PG Steg, ...
JACC: Cardiovascular Interventions 6 (7), 671-683, 2013
Left ventricular dysfunction in the setting of takotsubo cardiomyopathy: a review of clinical patterns and practical implications
K Yalta, M Yilmaztepe, C Zorkun
Cardiac failure review 4 (1), 14, 2018
Late versus early myocardial remodeling after acute myocardial infarction: a comparative review on mechanistic insights and clinical implications
K Yalta, MB Yilmaz, T Yalta, O Palabiyik, G Taylan, C Zorkun
Journal of cardiovascular pharmacology and therapeutics 25 (1), 15-26, 2020
Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction
V Kunadian, C Zorkun, SP Williams, LH Biller, AM Palmer, KJ Ogando, ...
Journal of thrombosis and thrombolysis 26, 234-242, 2008
Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals
D Dudek, K Żmudka, GL Kałuża, M Kuta, P Pieniążek, T Przewłocki, ...
American Journal of Cardiology 91 (2), 227-229, 2003
Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT …
C Michael Gibson, YB Pride, PE Aylward, JJ Col, SG Goodman, D Gulba, ...
Journal of thrombosis and thrombolysis 27, 11-17, 2009
Determinants of coronary collateral circulation in patients with coronary artery disease
C Zorkun, E Akkaya, A Zorlu, İ Tandoğan
Anatolian Journal of Cardiology 13 (2), 2013
Intracoronary administration of abciximab in ST-elevation myocardial infarction
CM Gibson, C Zorkun, V Kunadian
Circulation 118 (1), 6-8, 2008
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS …
YB Pride, S Mohanavelu, C Zorkun, V Kunadian, RP Giugliano, LK Newby, ...
JACC: Cardiovascular Interventions 5 (9), 927-935, 2012
Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin …
L Tokgözoğlu, R Özdemir, R Altındağ, C Ceyhan, E Yeter, C Öztürk, ...
Türk Kardiyoloji Derneği Arşivi 44 (1), 2016
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome
SH Shin, B Claggett, MA Pfeffer, H Skali, J Liu, D Aguilar, R Diaz, ...
European Journal of Heart Failure 22 (7), 1133-1143, 2020
Angiographic outcomes with early eptifibatide therapy in non–ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial)
V Kunadian, RP Giugliano, LK Newby, C Zorkun, J Guo, A Bagai, ...
The American Journal of Cardiology 113 (8), 1297-1305, 2014
Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive?
K Yalta, F Ucar, M Yilmaztepe, C Zorkun
Indian Heart Journal 70 (2), 326, 2018
The system can't perform the operation now. Try again later.
Articles 1–20